Inorganic element determinations: Arguments for their reimbursement by French national system of health insurance

被引：0

作者：

Arnaud, Josiane ^{[1
]}

Beauval, Nicolas ^{[2
]}

Bost, Muriel ^{[3
,4
]}

Fofou-Callierez, Ma'atem Beatrice ^{[5
]}

El Balkhi, Souleiman ^{[6
]}

Garnier, Robert ^{[7
]}

Lelievre, Benedicte ^{[8
]}

Romain, Sarah ^{[9
]}

Bouchet, Martine Ropert ^{[10
]}

Sadeg, Nouredine ^{[11
]}

Goulle, Jean Pierre ^{[12
]}

机构：

[1] CHU Grenoble Alpes, Unite Biochim Hormonale & Nutrit, CS 10217,Blvd Chantourne, F-38043 Grenoble 9, France

[2] CHU Lille, Unite Fonct Toxicol, F-59000 Lille, France

[3] Hosp Civils Lyon, Ctr Reference Natl Maladie Wilson, 59 Blvd Pinel, F-69500 Bron, France

[4] Hosp Civils Lyon, Ctr Biol & Anatomopathol Sud, Lab Anal Trace Biochim & Biol Mol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France

[5] CHRU Nancy, Lab Biochim Biol Mol Nutr Metab, 5 Rue Morvan, F-54500 Vandoeuvre Les Nancy, France

[6] CHU Limoges, Batiment CBRS, Serv Pharmacol Toxicol & Pharmacovigilance, Toxicol Analyt Environnementale & Sante Travail, 2 Ave Martin Luther King, F-87042 Limoges, France

[7] Hop Fernand Widal, Ctr Antipoison Paris, 200 Rue Faubourg St Denis, F-75010 Paris, France

[8] CHU Angers, Lab Pharmacol Toxicol, 4 Rue Larrey, F-49933 Angers 9, France

[9] CHRU Strasbourg, Lab Biochim & Biol Mol, 1 Pl Hop, F-67091 Strasbourg, France

[10] CHU Rennes, Lab Biochim Toxicol, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France

[11] Int Med Inst Toxicol & Pharmacol IMITOX, ZAC Les Portes de Oise, Rue Henri Becquerel,Voie 2,Batiment B8, F-60230 Chambly, France

[12] Univ Rouen, Dept Pharm, Aliments Bloproc Toxicol Environm, CS 76183,22 Blvd Gambetta, F-76183 Rouen 1, France

来源：

TOXICOLOGIE ANALYTIQUE ET CLINIQUE | 2020年 / 32卷 / 01期

关键词：

Biometals; Fluids and secretions; Hair; Biological monitoring; Health insurance analytical methods; RELATIVE EXCHANGEABLE COPPER; TOTAL HIP-ARTHROPLASTY; SERUM ZINC CONCENTRATIONS; TRACE-ELEMENTS; REFERENCE VALUES; SELENIUM STATUS; IONIC FLUORIDE; HAIR ANALYSIS; HEAVY-METALS; NORMAL RANGE;

D O I：

10.1016/j.toxac.2019.07.005

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

Aim. - The aim of this review is to demonstrate that the determination of several inorganic elements, not currently included in the list of analyses reimbursed by the French national system of health insurance, may be essential for the diagnosis and management of patients suffering from inorganic element deficiencies or overloads involving environmental, genetic or health conditions. Methods. - Recommendations related to inorganic element bioanalyses were searched from medical organisations, agencies and societies and were examined. Results. - These recommendations were summarized regarding different nutritional or clinical situations, environmental exposure or the presence of implanted medical devices. Conclusion. - Our group considers that the addition of various inorganic element determinations to the list of analyses reimbursed by the French national system of health insurance is urgently required and will improve medical care. (C) 2019 Societe Francaise de Toxicologie Analytique. Published by Elsevier Masson SAS. All rights reserved.

引用

页码：33 / 61

页数：29

共 50 条

[1] Inorganic element determinations: Arguments for their reimbursement by French National system of health insurance
Arnaud, Josiane
Beauval, Nicolas
Bost, Muriel
Fofou-Caillierez, Ma'atem Beatrice
El Balkhi, Souleiman
Garnier, Robert
Lelievre, Benedicte
Romain, Sarah
Bouchet, Martine Ropert
Sadeg, Nouredine
Goulle, Jean Pierre
[J]. ANNALES DE BIOLOGIE CLINIQUE, 2021, 79 (04) : 383 - 385
[2] HOSPITAL REIMBURSEMENT UNDER NATIONAL-HEALTH INSURANCE
LAVE, JR
LAVE, LB
[J]. HEALTH COMMUNICATIONS AND INFORMATICS, 1979, 5 (5-6) : 304 - 318
[3] Prescribing outside the limits of marketing authorizations and reimbursement by the French universal health insurance system
Avouac, B
[J]. JOINT BONE SPINE, 2002, 69 (06) : 534 - 537
[4] Physicians' perception of the reform of the review and assessment system of national health insurance reimbursement claims
Lee, Jung Chan
Kim, Kye Hyun
[J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (12): : 841 - 849
[5] THE FINANCIAL IMPACT OF FEBUXOSTAT REIMBURSEMENT TO THE TAIWAN NATIONAL HEALTH INSURANCE
Liu, P. J.
Lu, Z. F.
Hsu, C. N.
Chan, Y. Y.
[J]. VALUE IN HEALTH, 2019, 22 : S594 - S594
[6] CLAIMS REIMBURSEMENT ANALYSIS OF THE NATIONAL HEALTH INSURANCE SCHEME IN GHANA
Nsiah-Boateng, E.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A432 - A432
[7] Evolution of Opioids Reimbursement since 2004 from the National Database of the General Health Insurance System
Pauly, Vanessa
Pradel, Vincent
Frauger, Elisabeth
Micallef, Joelle
Thirion, Xavier
[J]. THERAPIE, 2011, 66 (04): : 369 - 372
[8] REIMBURSEMENT LAG OF INNOVATIVE NEW DRUGS UNDER TAIWAN'S NATIONAL HEALTH INSURANCE SYSTEM
Shih, Y.
Wang, C.
Wen, Y.
Chen, Y.
Lin, F.
Hsiao, F.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A43 - A43
[9] French national health insurance information system and the permanent beneficiaries sample
Tuppin, P.
de Roquefeuil, L.
Weill, A.
Ricordeau, P.
Merliere, Y.
[J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2010, 58 (04): : 286 - 290
[10] French Health big data experience: The evolution of the national health insurance information system
Le Meur, N.
Gao, F.
[J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30

← 1 2 3 4 5 →